New hope for advanced cancer patients: first human trial of experimental oral drug begins
Disease control
Recruiting now
This is the first human study of an experimental oral medication called APR-1051 for people with advanced solid tumors that have spread or cannot be surgically removed. The main goals are to determine safe dosage levels, understand how the drug moves through the body, and look fo…
Phase: PHASE1 • Sponsor: Aprea Therapeutics • Aim: Disease control
Last updated Mar 30, 2026 14:34 UTC